Fig. 2.
Tumor-free survival of mice receiving neo-transduced fibroblasts (n = 28) or CD40L and IL-2 transduced cells (n = 28). Only in the CD40L and IL-2 group was there discernible long-term tumor-free survival and absence of tumor at necropsy.
Tumor-free survival of mice receiving neo-transduced fibroblasts (n = 28) or CD40L and IL-2 transduced cells (n = 28). Only in the CD40L and IL-2 group was there discernible long-term tumor-free survival and absence of tumor at necropsy.
